MeSH term
Frequency | Condition_Probility | Female | 3 | 0.0 |
Humans | 19 | 0.0 |
Amino Acid Sequence | 6 | 0.0 |
Angiogenesis Inhibitors/pharmacology | 2 | 5.0 |
Animals | 9 | 0.0 |
Fatty Acids, Unsaturated/pharmacology | 5 | 7.0 |
Mice | 4 | 0.0 |
Molecular Sequence Data | 6 | 0.0 |
Research Support, Non-U.S. Gov't | 12 | 0.0 |
Sesquiterpenes/pharmacology | 2 | 12.0 |
Spodoptera | 2 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Angiogenesis Inhibitors/*pharmacology | 5 | 5.0 |
Binding Sites | 2 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Aminopeptidases/*genetics | 2 | 22.0 |
Cell Line, Tumor | 3 | 0.0 |
Metalloendopeptidases/*genetics | 2 | 2.0 |
Cell Division/drug effects | 8 | 0.0 |
Transfection | 3 | 0.0 |
Cell Cycle/drug effects | 2 | 0.0 |
Cells, Cultured | 5 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 6 | 0.0 |
Sesquiterpenes/*pharmacology | 4 | 11.0 |
Aminopeptidases/*biosynthesis | 2 | 66.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Metalloendopeptidases/*biosynthesis | 2 | 9.0 |
Male | 2 | 0.0 |
Aminopeptidases/*antagonists & inhibitors | 5 | 83.0 |
Aorta | 2 | 1.0 |
Cattle | 4 | 0.0 |
Endothelium, Vascular/cytology/*drug effects/metabolism | 2 | 2.0 |
Glyceraldehyde-3-Phosphate Dehydrogenases/chemistry/*metabolism | 2 | 100.0 |
Metalloendopeptidases/*antagonists & inhibitors | 5 | 18.0 |
Methionine/*metabolism | 2 | 10.0 |
Myristic Acid/metabolism | 2 | 8.0 |
Peptide Fragments/chemistry | 2 | 1.0 |
Protein Processing, Post-Translational/*drug effects | 2 | 3.0 |
Recombinant Proteins/chemistry/metabolism | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Umbilical Veins | 3 | 0.0 |
Neovascularization, Pathologic/*prevention & control | 2 | 3.0 |
Endothelium, Vascular/cytology/drug effects | 2 | 3.0 |
Substrate Specificity | 2 | 0.0 |
Blotting, Western | 2 | 0.0 |
Models, Molecular | 3 | 0.0 |
